and is needed to determine whether muscle tissue utilizes carbohydrates or fat for energy
But visible body-composition changes are slow and modest
Ghrelin Receptor (GHS-R1a) Selective Activation Ipamorelin acts as a highly selective agonist of the growth hormone secretagogue receptor (GHS-R1a), mimicking the natural hormone ghrelin without affecting other pituitary hormone secretion: Selective binding to GHS-R1a receptors without stimulating ACTH, cortisol, or prolactin release Rapid onset of growth hormone pulse generation (peak levels within 40-60 minutes) No significant effect on appetite stimulation unlike other ghrelin mimetics Preserved feedback regulation through endogenous growth hormone-releasing inhibitory mechanisms Research indicates that ipamorelin releases growth hormone with potency and efficacy similar to GHRP-6 (EC50 approximately 1.3 nmol/L) but with superior selectivity for growth hormone secretion

Based on practitioner reports and patient experience (not controlled clinical trials, which do not yet exist for IGF-1 LR3 in humans): Individual results vary based on training consistency, nutrition, dosing, genetics, and baseline fitness level
Those 100 units equal exactly 1mL of liquid
Keep the product out of the reach of younger children